Seroprevalence of some vector-borne infections of dogs in Hungary

匈牙利犬类某些媒介传播感染的血清流行率

阅读:1

Abstract

The first comprehensive study on the prevalence of canine vector-borne pathogens (Anaplasma phagocytophilum, Borrelia burgdorferi, Ehrlichia canis, and Dirofilaria immitis) was carried in Hungary because, except for babesiosis and dirofilariosis caused by Dirofilaria repens, there were no data on their regional distribution and prevalence. In 2011 and 2012, 1305 blood samples were collected from randomly selected, apparently healthy pet dogs in 167 localities of 19 counties of Hungary. All sera samples from dogs were screened for simultaneous qualitative detection of circulating antibodies to E. canis and B. burgdorferi sensu lato and A. phagocytophilum and D. immitis antigen using SNAP(®) 4Dx (IDEXX Laboratories). Overall, 170 dogs (13.0%; 95% confidence interval [CI] 11-15) were serologically positive to one or more of the tested pathogens. A. phagocytophilum was the most prevalent pathogen detected in 102 dogs by antibody titers (7.9%, 95% CI 6.5-9.5), followed by D. immitis (2.4%, 95% CI 1.0-4.0, n=64) and B. burgdorferi (0.4%, 95% CI 0.0-1.1, n=11) out of 1305 tested dogs. The least prevalent infection was with E. canis, with only two positive dogs (0.16%, 95% CI 0.03-0.6). Co-infection was found in eight dogs (0.61%, 95% CI 0.29-1.21), of which seven were seropositive to two pathogens (five with A. phagocytophilum and D. immitis, two with A. phagocytophilum and B. burgdorferi). One dog was serologically positive to three pathogens (A. phagocytophilum, B. burgdorferi, and D. immitis). Purebred and crossbred animals did not show significantly different levels of seropositivity. There was no significant association between the gender and the results of diagnostic testing. Logistic regression analysis showed a higher chance of seropositivity in the older dogs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。